MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

13 Nov 2024 Evaluate
The sales moved up 31.16% to Rs. 4080.00 millions for the September 2024 quarter as compared to Rs. 3110.70 millions during the year-ago period.A slender decline of -26.62% was recorded to Rs. 384.30  millions from Rs. 523.70 millions in the corresponding previous quarter.Operating profit for the quarter ended September 2024 decreased to 606.90 millions as compared to 611.30 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 4080.00 3110.70 31.16 7955.20 6065.40 31.16 12955.28 10029.71 29.17
Other Income 81.50 83.70 -2.63 165.00 164.70 0.18 348.00 261.02 33.32
PBIDT 606.90 611.30 -0.72 1071.10 1364.70 -21.51 2192.52 1912.27 14.66
Interest 3.40 5.00 -32.00 4.50 6.50 -30.77 12.01 6.33 89.73
PBDT 603.50 770.60 -21.68 491.00 1522.50 -67.75 2344.77 1503.65 55.94
Depreciation 93.20 36.80 153.26 132.30 74.70 77.11 149.40 162.60 -8.12
PBT 510.30 733.80 -30.46 358.70 1447.80 -75.22 2195.37 1341.05 63.71
TAX 126.00 210.10 -40.03 92.30 385.50 -76.06 580.28 348.12 66.69
Deferred Tax -21.00 -2.80 650.00 -162.20 -2.10 7623.81 -9.03 -34.90 -74.13
PAT 384.30 523.70 -26.62 266.40 1062.30 -74.92 1615.09 992.93 62.66
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 14.88 19.65 -24.31 13.46 22.50 -40.16 16.92 19.07 -11.24
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..